Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance
Public ClinicalTrials.gov record NCT03980730. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled, Multicenter Studies to Evaluate the Safety and Efficacy of Azeliragon as a Treatment for Subjects With Mild Alzheimer's Disease and Impaired Glucose Tolerance
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the efficacy and safety of azeliragon in patients with mild Alzheimer's disease and impaired glucose tolerance. Patients will receive either azeliragon or placebo with a patient's participation lasting approximately 9 months (in Part 1) or 21 months (in Part 2).
Study identification
- NCT ID
- NCT03980730
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2019 (Actual)
- Primary completion
- Dec 1, 2020 (Actual)
- Completion
- Jan 29, 2021 (Actual)
- Last update posted
- Jan 21, 2022
2019 – 2021
United States locations
- U.S. sites
- 27
- U.S. states
- 12
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson Neuroscience Research | Tucson | Arizona | 85710 | — |
| Institute for Neurodegenerative Disorders | New Haven | Connecticut | 06510 | — |
| JEM Research Institute | Atlantis | Florida | 33462 | — |
| Brain Matters Research | Delray Beach | Florida | 33445 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Charter Research | Lady Lake | Florida | 32159 | — |
| Alzheimer's Research and Treatment Center | Lake Worth | Florida | 33449 | — |
| ClinCloud | Maitland | Florida | 32751 | — |
| Synexus Clinical Research US | Orlando | Florida | 32806 | — |
| Emerald Coast Center for Neurological Disorders | Pensacola | Florida | 32514 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| The Roskamp Institute | Sarasota | Florida | 34243 | — |
| Brain Matters Research | Stuart | Florida | 34997 | — |
| Emory Alzheimer's Clinical Research Unit | Atlanta | Georgia | 30329 | — |
| NeuroStudies.net LLC | Decatur | Georgia | 30033 | — |
| IU Health Partners, Adult Neurology Clinic | Indianapolis | Indiana | 46202 | — |
| Memory Center / Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| Millennium Psychiatric Associates | St Louis | Missouri | 63132 | — |
| The Cognitive and Research Center of New Jersey | Springfield | New Jersey | 07081 | — |
| Clarity Clinical Research | East Syracuse | New York | 13057 | — |
| Neurological Associates of Long Island | Lake Success | New York | 11042 | — |
| ANI Neurology dba Alzheimer's Memory Center | Charlotte | North Carolina | 28270 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| Wake Forest School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Center for Cognitive Health | Portland | Oregon | 97225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03980730, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03980730 live on ClinicalTrials.gov.